A case of BNT162b2 COVID-19 vaccine-associated fulminant myocarditis in a very elderly woman

Kaishi Otsuka; Takashi Matsuo; Takashi Ishimatsu; Atsuki Fukae; Takuro Hamamoto; Koji Oku; Masahiro Ito

doi:10.22541/au.164344047.78701853/v1

loading page

A case of BNT162b2 COVID-19 vaccine-associated fulminant myocarditis in a very elderly woman

Kaishi Otsuka,
Takashi Matsuo,
Takashi Ishimatsu,
Atsuki Fukae,
Takuro Hamamoto,
Koji Oku,
Masahiro Ito

Abstract

Coronavirus disease 2019 (COVID-19) vaccination is reportedly safe and effective. The histologic features of post-COVID-19 vaccination myocarditis are unknown. We present a 77-year-old Japanese woman who was diagnosed with eosinophilic myocarditis using endomyocardial biopsy, 7 days after receiving the second dose of BNT162b2 COVID-19 vaccine. Methylprednisolone pulse therapy was effective.

16 Jan 2022Submitted to Clinical Case Reports

Show details

Hide details

27 Jan 2022Submission Checks Completed

27 Jan 2022Assigned to Editor

29 Jan 2022Reviewer(s) Assigned

02 Mar 2022Review(s) Completed, Editorial Evaluation Pending

02 Mar 2022Editorial Decision: Revise Minor

11 Mar 20221st Revision Received

15 Mar 2022Submission Checks Completed

15 Mar 2022Assigned to Editor

15 Mar 2022Review(s) Completed, Editorial Evaluation Pending

20 Mar 2022Editorial Decision: Revise Minor

13 Apr 20222nd Revision Received

15 Apr 2022Assigned to Editor

15 Apr 2022Submission Checks Completed

15 Apr 2022Review(s) Completed, Editorial Evaluation Pending

22 Apr 2022Editorial Decision: Accept

Sep 2022Published in Clinical Case Reports volume 10 issue 9. 10.1002/ccr3.6161

Abstract

Peer review status:Published